Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized, Controlled Trial of Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AM

NCT06565156 is registered in ClinicalTrials.gov with BioStem Technologies as lead sponsor.

NCT NCT06565156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06565156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized, Controlled Trial of Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AM
Lead sponsor
BioStem Technologies
Phase
Not applicable
Overall status
Completed
Start date
October 28, 2024
Completion date
April 30, 2026
Enrollment
72 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot, diabetic foot ulcer, diabetic wound, non-infected diabetic foot ulcer, non-ischemic diabetic foot ulcer